| Code | CSB-RA023603MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to EB-07, targeting Toll-like receptor 4 (TLR4), a critical pattern recognition receptor in the innate immune system. TLR4 functions as the primary sensor for lipopolysaccharide (LPS) from Gram-negative bacteria, initiating inflammatory signaling cascades through MyD88-dependent and TRIF-dependent pathways. Upon activation, TLR4 triggers the production of pro-inflammatory cytokines and type I interferons, playing essential roles in host defense against pathogens. Dysregulated TLR4 signaling is implicated in numerous pathological conditions, including sepsis, inflammatory bowel disease, atherosclerosis, neurodegenerative disorders, and various autoimmune diseases, making it a significant target for immunological research.
The reference antibody EB-07 has been utilized in studies investigating TLR4 expression, localization, and functional activity across diverse experimental models. This biosimilar provides researchers with a reliable tool for exploring TLR4-mediated immune responses, examining inflammatory mechanisms, and investigating potential therapeutic interventions in TLR4-associated diseases. The antibody supports investigations into innate immunity, host-pathogen interactions, and inflammation-related pathophysiology.
There are currently no reviews for this product.